Gut Microbiome

Exposure to antibiotics with anaerobe coverage in later life is associated with higher enteric pathobiont carriage.

TL;DR

Exposure to antibiotics with anaerobe coverage is associated with higher rates of enteric pathobiont carriage and relative abundance in long-term residential aged care residents, even where pathobiont species are sensitive to the administered antibiotic.

Key Findings

The vast majority of long-term care residents carried at least one enteric pathobiont.

  • 138 of 164 participants (84.1%) carried at least one enteric pathobiont
  • Median age of participants was 87.9 years (interquartile range: 81.3–93.0 years)
  • Stool samples underwent metagenomic analysis
  • Study population consisted of long-term residential aged care (LTC) residents

Treatment with antibiotics that cover anaerobes (EAC) was associated with higher rates of pathobiont carriage compared to those with no prior antibiotic exposure.

  • β=1.36, P=0.010 for pathobiont carriage rates
  • Association was identified using multivariable models
  • Antibiotics were categorised according to anaerobe coverage and type
  • Comparison was made against participants with no prior antibiotic exposure

Exposure to antibiotics with anaerobe coverage (EAC) was associated with higher overall pathobiont relative abundance.

  • β=3.53, P=0.013 for overall pathobiont relative abundance
  • Association identified through multivariable modelling
  • Effect was specific to EAC antibiotics and not seen with limited anaerobe coverage (LAC) antibiotics

Antibiotics with limited anaerobe coverage (LAC) showed no significant associations with pathobiont carriage or relative abundance.

  • No statistically significant associations were found between LAC antibiotic exposure and pathobiont carriage rates
  • No statistically significant associations were found between LAC antibiotic exposure and pathobiont relative abundance
  • This contrasts directly with findings for EAC antibiotics
  • Results suggest the anaerobe-depleting property of antibiotics is specifically linked to pathobiont expansion

Amoxicillin-clavulanate (a commonly prescribed EAC antibiotic) was specifically associated with higher pathobiont detection and relative abundance.

  • β=1.60, P=0.007 for higher detection of pathobiont species in amoxicillin-clavulanate recipients
  • β=3.32, P=0.039 for higher relative abundance of pathobiont species
  • Cefalexin, a commonly prescribed LAC antibiotic, did not show the same associations
  • Findings were consistent with the broader EAC vs. LAC comparison

Pathobionts with greater representation in amoxicillin-clavulanate recipients included both antibiotic-resistant and antibiotic-sensitive species.

  • Enterococcus faecium, which has inherent resistance to amoxicillin-clavulanate, showed greater representation
  • Klebsiella pneumoniae, which is sensitive to amoxicillin-clavulanate, also showed greater representation
  • This indicates that pathobiont expansion is not solely explained by direct antibiotic selection pressure on resistant organisms
  • Authors interpret this as evidence that off-target disruption of commensal anaerobes drives pathobiont expansion

The study concluded that off-target disruption of commensal anaerobes should be considered when selecting antibiotic treatments in long-term care populations.

  • Authors state: 'Antibiotics that deplete commensal anaerobes are associated with pathobiont prevalence in the gut, even where pathobiont species are sensitive to the administered antibiotic'
  • Authors recommend that 'off-target disruption of commensal anaerobes should be considered when selecting antibiotic treatments, particularly for LTC individuals'
  • The mechanism proposed links anaerobe depletion to loss of colonisation resistance, enabling pathobiont expansion
  • LTC populations were identified as particularly relevant given their high infection risk from enteric bacteria

What This Means

This research suggests that the type of antibiotic prescribed to elderly residents in long-term care facilities matters beyond just treating the immediate infection. Specifically, antibiotics that kill anaerobic bacteria — a group of beneficial gut microbes — were associated with a significantly higher likelihood of residents harboring potentially dangerous gut bacteria called pathobionts. In contrast, antibiotics that spare these anaerobic bacteria were not linked to increased pathobiont presence. Over 84% of the 164 residents studied already carried at least one such pathobiont, highlighting how common this phenomenon is in this population. A particularly notable finding was that even pathobionts that should be killed by the antibiotic being used (such as Klebsiella pneumoniae being sensitive to amoxicillin-clavulanate) were found at higher levels in people who received that antibiotic. This suggests the problem is not simply that antibiotics wipe out susceptible bacteria and leave resistant ones to flourish. Instead, the research points to a broader ecological disruption: when beneficial anaerobic bacteria in the gut are depleted, they can no longer keep potentially harmful bacteria in check — a protective function known as colonisation resistance. This research suggests that when doctors choose antibiotics for elderly people in care homes, the impact on the broader gut bacterial community — particularly anaerobic commensals — should be factored into the decision, not just the antibiotic's effectiveness against the target infection. Selecting antibiotics that preserve gut anaerobes where clinically appropriate may help reduce the risk of subsequent infections caused by opportunistic gut bacteria in this vulnerable population.

Have a question about this study?

Citation

Vasil E, Papanicolas L, Miller S, Shoubridge A, Taylor S, Rogers G. (2026). Exposure to antibiotics with anaerobe coverage in later life is associated with higher enteric pathobiont carriage.. The Journal of infection. https://doi.org/10.1016/j.jinf.2026.106774